Throughout 2019, Cigna will continue to leverage our recent combination with Express Scripts to increase affordability for members. We will send regular updates so you understand what is happening, when, and how it may or may not impact your members. Today, I’m writing to share important information about Accredo specialty pharmacy and Freedom Fertility:
Transition to Accredo for specialty medications and Freedom Fertility for fertility treatments
Later this year we will tap Express Scripts’ specialty pharmacy arm, Accredo, for members who use specialty medications and fertility treatments.
- Accredo is an industry-leading specialty pharmacy with more than 35 years’ experience in specialty pharmacy operations, condition-specific clinical programs and most importantly, superior and compassionate customer care. Cigna will implement a phased approach, beginning in Q2 and continuing through Q4. Payer Solutions is scheduled to move in the fourth quarter 2019.
- Cigna will also begin to work with Freedom Fertility, Accredo’s resource for fertility treatments, in August. Members currently undergoing fertility treatments may maintain existing arrangements; members newly entering fertility treatments will access their medications through Freedom Fertility after the transition date.
Cigna is working hard to ensure a smooth transition for your members. Watch for more communications about the move to Accredo and Freedom Fertility later this summer. For more information please see the attached flyer.
We appreciate your collaboration as we work to add value to Cigna’s pharmacy offering and increase affordability for your clients and members. We will share additional information about these specific initiatives later this year.
